Neoadjuvant Chemoradiation With or Without PD-1 Blockade in Locally Advanced Rectal Cancer: A Randomized Phase II Trial

Scientists evaluated the efficacy and safety of the radiation–immune checkpoint inhibitor combination in patients with locally advanced rectal cancer in a Phase II, randomized trial conducted in eight major colorectal cancer centers in Beijing.